Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydroxymethylglutaryl CoA Reductases | 13 | 2004 | 17 | 1.800 |
Why?
|
| Mevalonic Acid | 8 | 2004 | 27 | 1.020 |
Why?
|
| Monoterpenes | 5 | 2013 | 8 | 0.880 |
Why?
|
| RNA, Messenger | 13 | 2012 | 1663 | 0.690 |
Why?
|
| Hydroxycholesterols | 8 | 1997 | 10 | 0.510 |
Why?
|
| Lovastatin | 8 | 2003 | 78 | 0.500 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2013 | 282 | 0.480 |
Why?
|
| Cricetinae | 13 | 2013 | 262 | 0.460 |
Why?
|
| Eukaryotic Initiation Factor-4E | 2 | 2013 | 19 | 0.420 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2011 | 3 | 0.410 |
Why?
|
| Base Pairing | 1 | 2011 | 15 | 0.410 |
Why?
|
| Sequence Deletion | 1 | 2011 | 89 | 0.390 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2011 | 35 | 0.390 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2003 | 212 | 0.380 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 214 | 0.380 |
Why?
|
| Cladribine | 1 | 2010 | 1 | 0.370 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 301 | 0.360 |
Why?
|
| Telomerase | 3 | 2013 | 85 | 0.320 |
Why?
|
| RNA Processing, Post-Transcriptional | 4 | 1995 | 43 | 0.310 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2007 | 4 | 0.310 |
Why?
|
| Genistein | 1 | 2007 | 26 | 0.310 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 1070 | 0.280 |
Why?
|
| Phosphoproteins | 1 | 2007 | 202 | 0.280 |
Why?
|
| Protein Biosynthesis | 5 | 1997 | 181 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 331 | 0.260 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2004 | 3 | 0.260 |
Why?
|
| Proto-Oncogenes | 1 | 2004 | 37 | 0.250 |
Why?
|
| Enzyme Inhibitors | 3 | 2012 | 659 | 0.250 |
Why?
|
| Sirolimus | 3 | 2013 | 118 | 0.240 |
Why?
|
| Sterols | 2 | 2001 | 13 | 0.230 |
Why?
|
| Cell Line | 8 | 2013 | 1752 | 0.210 |
Why?
|
| Mesocricetus | 5 | 2003 | 32 | 0.200 |
Why?
|
| Kidney | 3 | 2003 | 945 | 0.200 |
Why?
|
| Cycloheximide | 3 | 1995 | 50 | 0.190 |
Why?
|
| Animals | 19 | 2015 | 20877 | 0.190 |
Why?
|
| Colonic Neoplasms | 1 | 2001 | 299 | 0.170 |
Why?
|
| Intramolecular Transferases | 1 | 1998 | 1 | 0.170 |
Why?
|
| Benzophenones | 1 | 1998 | 12 | 0.170 |
Why?
|
| Polyribosomes | 2 | 1995 | 24 | 0.170 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 475 | 0.170 |
Why?
|
| Simvastatin | 1 | 1998 | 34 | 0.160 |
Why?
|
| Neoplasms | 2 | 2007 | 1660 | 0.160 |
Why?
|
| Base Sequence | 6 | 2011 | 1015 | 0.150 |
Why?
|
| Farnesyl-Diphosphate Farnesyltransferase | 1 | 1997 | 1 | 0.150 |
Why?
|
| Lyases | 1 | 1997 | 4 | 0.150 |
Why?
|
| Transcription, Genetic | 4 | 2004 | 562 | 0.140 |
Why?
|
| Ribosomes | 1 | 1995 | 23 | 0.140 |
Why?
|
| Suppression, Genetic | 1 | 1995 | 10 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 1446 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 43 | 0.130 |
Why?
|
| DNA, Complementary | 2 | 2011 | 251 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2013 | 118 | 0.130 |
Why?
|
| Transfection | 3 | 2013 | 782 | 0.120 |
Why?
|
| CHO Cells | 3 | 2013 | 161 | 0.120 |
Why?
|
| Hypoxia | 1 | 2015 | 169 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2012 | 756 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 710 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 82 | 0.110 |
Why?
|
| Cloning, Molecular | 2 | 1983 | 357 | 0.100 |
Why?
|
| Reverse Transcription | 1 | 2011 | 3 | 0.100 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2011 | 16 | 0.100 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2011 | 44 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 1995 | 1293 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 159 | 0.100 |
Why?
|
| Prostate | 1 | 2011 | 116 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2003 | 2673 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1992 | 284 | 0.090 |
Why?
|
| Brain | 2 | 2015 | 2175 | 0.090 |
Why?
|
| Leukemia | 1 | 2010 | 117 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 1988 | 2 | 0.090 |
Why?
|
| Oxo-Acid-Lyases | 1 | 1988 | 2 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2013 | 1199 | 0.080 |
Why?
|
| Cricetulus | 3 | 2013 | 98 | 0.080 |
Why?
|
| Humans | 11 | 2015 | 68525 | 0.070 |
Why?
|
| Cell Survival | 1 | 2010 | 901 | 0.070 |
Why?
|
| Alternative Splicing | 2 | 1998 | 93 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 1849 | 0.070 |
Why?
|
| RNA, Transfer, Amino Acyl | 2 | 1986 | 3 | 0.070 |
Why?
|
| Dictyostelium | 2 | 1986 | 7 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 230 | 0.070 |
Why?
|
| RNA | 2 | 2003 | 171 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2013 | 447 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2013 | 17 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1745 | 0.060 |
Why?
|
| Autoradiography | 1 | 2003 | 94 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2003 | 31 | 0.060 |
Why?
|
| Apoptosis | 1 | 2010 | 1640 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2001 | 37 | 0.050 |
Why?
|
| Stroke | 1 | 2015 | 2161 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2003 | 122 | 0.050 |
Why?
|
| DNA, Recombinant | 1 | 1981 | 25 | 0.050 |
Why?
|
| Genes | 1 | 1981 | 86 | 0.050 |
Why?
|
| Terpenes | 1 | 1999 | 18 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 614 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1999 | 88 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 92 | 0.040 |
Why?
|
| Cathepsin B | 1 | 1998 | 33 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2007 | 2688 | 0.040 |
Why?
|
| Tricarboxylic Acids | 1 | 1997 | 3 | 0.040 |
Why?
|
| Naphthols | 1 | 1997 | 5 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 1997 | 64 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 1998 | 343 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 1995 | 18 | 0.030 |
Why?
|
| Depression, Chemical | 1 | 1995 | 29 | 0.030 |
Why?
|
| Globins | 1 | 1995 | 13 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1995 | 118 | 0.030 |
Why?
|
| Culture Media | 1 | 1995 | 155 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1995 | 191 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1995 | 260 | 0.030 |
Why?
|
| Melanoma | 1 | 1998 | 335 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1994 | 4 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1993 | 31 | 0.030 |
Why?
|
| Male | 4 | 2012 | 37281 | 0.030 |
Why?
|
| Actins | 1 | 1995 | 249 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1994 | 66 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 376 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2013 | 25 | 0.030 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2013 | 3 | 0.030 |
Why?
|
| Leupeptins | 1 | 2012 | 23 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 132 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 56 | 0.030 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 46 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 1994 | 305 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1983 | 95 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2012 | 73 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1992 | 165 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1992 | 358 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 791 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2013 | 682 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 954 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1027 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 1082 | 0.020 |
Why?
|
| Liver | 1 | 1994 | 1118 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2550 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 852 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1987 | 137 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1986 | 23 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 778 | 0.020 |
Why?
|
| Cholesterol | 1 | 1987 | 331 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1985 | 164 | 0.020 |
Why?
|
| Ovary | 1 | 1985 | 99 | 0.020 |
Why?
|
| Kinetics | 1 | 1985 | 1047 | 0.010 |
Why?
|
| Mutation | 1 | 1988 | 1213 | 0.010 |
Why?
|
| Poly A | 1 | 1983 | 14 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1983 | 396 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1981 | 49 | 0.010 |
Why?
|
| Base Composition | 1 | 1981 | 22 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1981 | 37 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1981 | 92 | 0.010 |
Why?
|
| Plasmids | 1 | 1981 | 258 | 0.010 |
Why?
|
| DNA | 1 | 1983 | 597 | 0.010 |
Why?
|
| Plants, Edible | 1 | 1999 | 3 | 0.010 |
Why?
|
| Phytotherapy | 1 | 1999 | 53 | 0.010 |
Why?
|
| Mice | 2 | 1999 | 8472 | 0.010 |
Why?
|
| Organelles | 1 | 1998 | 18 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1998 | 86 | 0.010 |
Why?
|
| Exons | 1 | 1998 | 122 | 0.010 |
Why?
|
| COS Cells | 1 | 1998 | 155 | 0.010 |
Why?
|
| Protein Folding | 1 | 1998 | 82 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 302 | 0.010 |
Why?
|
| Aging | 1 | 1983 | 911 | 0.010 |
Why?
|
| Diet | 1 | 1999 | 513 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1994 | 17 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1994 | 45 | 0.010 |
Why?
|
| Half-Life | 1 | 1994 | 96 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 119 | 0.010 |
Why?
|
| Temperature | 1 | 1994 | 340 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 2083 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 1987 | 90 | 0.000 |
Why?
|
| Hypercholesterolemia | 1 | 1987 | 86 | 0.000 |
Why?
|
| Female | 2 | 1987 | 38015 | 0.000 |
Why?
|
| Rats | 1 | 1994 | 5300 | 0.000 |
Why?
|
| Risk Factors | 1 | 1987 | 5719 | 0.000 |
Why?
|